Senior insider sale
Chief Scientific Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.04M
51.86K shares
LILLIE JAMES WOODRUFF plans to sell 51.86K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.04M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2025 | Restricted Stock Unit Grant N/A | 8.13K | — |
7/18/2025 | Restricted Stock Unit Grant N/A | 5.53K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 6.15K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.43K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.20K | — |
| Total | 24.44K | ||
Completed
Units to sell
22.08K
Market value
$277.0K
Units to sell
2.08K
Market value
$78.7K
Units to sell
8.55K
Market value
$314.4K
Units to sell
7.64K
Market value
$280.4K
Planned — Approximate Date
Units to sell
11.51K
Market value
$89.9K
Units
51.86K
Value
$1.04M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 22.08K | $277.0K | — | Completed |
7/17/2026 | 2.08K | $78.7K | — | Completed |
7/16/2026 | 8.55K | $314.4K | — | Completed |
7/15/2026 | 7.64K | $280.4K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 11.51K | $89.9K | NASDAQ | Planned |
| Total | 51.86K | $1.04M | ||